Mortality rates for U.S. patients with oral and pharyngeal cancer decreased from 1993 to 2007, according to a study in the Archives of Otolaryngology —

Limits on smokeless tobacco use included in the new Major League Baseball (MLB) contract represent a historic first step to protect the health of big

Many of the common orthodontic problems experienced by people in industrialized nations are due to their soft modern diet causing the mandible to grow too

A joint campaign by the Academy of General Dentistry (AGD) and the North American Center for Continuing Medical Education (NACCME) showed that dental professionals helped

The International Agency for Research on Cancer, part of the World Health Organization (WHO), predicts that more than 790,000 people worldwide will be diagnosed with

Cytomegalovirus (CMV) has been confirmed as a cause of the most common salivary gland cancers (Experimental and Molecular Pathology, November 10, 2011). CMV joins a

Chemoradiation for patients with stage-four (T4) laryngeal cancer appears to be an effective and reasonable treatment option, according to a study in Head & Neck

The National Comprehensive Cancer Network (NCCN) Oncology Research Program has been awarded a $2 million grant from Boehringer Ingelheim Pharmaceuticals to develop a program to

A professor of oral medicine at King’s College London has expressed concern about the lack of improvement in U.K. oral cancer survival rates compared with

The U.S. Food and Drug Administration (FDA) has approved Erbitux (cetuximab) for use with chemotherapy to aid in the treatment of patients with late-stage head